CCR5 Density on CD4 Cells Governs Course of HIV Infection in Children -- HIV/AIDS INFO AND UPDATES

[ Show ]

Support VoyForums

[ Shrink ]

VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

[ Login ] [ Contact Forum Admin ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1 ]

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Date Posted: 12:21:51 05/16/02 Thu
Author: Anonymous
Subject: CCR5 Density on CD4 Cells Governs Course of HIV Infection in Children

http://www.medscape.com/viewarticle/432289_print

CCR5 Density on CD4 Cells Governs Course of HIV Infection in Children

Reuters Health Information 2002. � 2002 Reuters Ltd
Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
Introduction
NEW YORK (Reuters Health) Apr 19 - The density of CC chemokine receptor 5 (CCR5) molecules on the surface of inactivated CD4 cells correlates with disease progression and with treatment response in children vertically infected with HIV. Development of therapy to reduce CCR5 density could therefore be expected to slow disease progression and increase response to treatment, a team of French and Swiss investigators suggests.

Dr. Pierre Corbeau, of the Hopital Saint Eloi in Montpellier, France, and associates monitored the density of CCR5 molecules on CD4 cells in 22 HIV-infected children for 12 months. As reported in The Journal of Infectious Diseases for April 15, the density remained stable over time.

Among 35 therapy-na ve children, ages 10 to 201 months, the CCR5 density was correlated with severity of disease according to clinical and biologic stage (p < 0.001) and annual percentage of CD4 cell loss (p = 0.034). CD4 cell loss was dramatically increased when CCR5 density exceeded 10,000 molecules per cell.

The CCR5 density was also associated with the drop in viral load among 21 children who initiated treatment with two nucleoside inhibitors and one protease inhibitor (p = 0.026).

Dr. Corbeau's team theorizes that viral replication is more difficult to block when cells express high densities of CCR5 molecules. Specifically, "In high CCR5 expressers, low residual viremia will result in the productive infection of cells with a high density of membrane CCR5, and replication will be sustained."

The authors conclude that determination of CCR5 density could aid in determining prognosis and in decision-making regarding treatment.

J Infect Dis 2002;185:1055-1061.

[ Next Thread | Previous Thread | Next Message | Previous Message ]